I A Global Asset Management Inc. Axonics, Inc. Transaction History

I A Global Asset Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 15, 2023	SELL	$48.64 - $62.51 $170,240 - $218,785	-3,500 Reduced 9.27%	34,240 $1.92 Million
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $1.81 Million - $2.27 Million	37,740 New	37,740 $1.91 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on I A Global Asset Management Inc. with notifications on news.